Toxicological Evaluation of D-Allulose from a Novel One-Step Fermentation Process Using Genetically Engineered E. coli

A new production route just cleared a major safety hurdle

Researchers put fermentation-derived D-allulose through a full 90-day oral toxicity study in rats. The result? A no-observed-adverse-effect level of 8,000 mg per kilogram of body weight per day. That is the highest dose tested. No adverse effects appeared at any level.

This matters if you are evaluating new suppliers. The sweetener in this study came from a genetically engineered E. coli strain called AS10. It produces allulose in a single fermentation step. Older enzymatic methods require multiple processing stages. One-step fermentation can mean lower costs, higher yields, and a simpler supply chain. The question was whether the final ingredient carries any new toxicological risk. This study says no.

Why allulose keeps showing up in your inbox

D-allulose delivers the bulk and mouthfeel of sucrose at a fraction of the calories. Its physicochemical properties line up closely with sugar. Solubility, texture, thermal stability — all comparable. Bakery, beverage, and confectionery formulators already treat it as a near drop-in replacement.

The production method shapes cost and availability. A one-step fermentation process changes the economics. That is why ingredient buyers are watching this data closely.

What the study actually did

The research team engineered E. coli AS10 to convert substrates into D-allulose through fermentation. They then purified the resulting sweetener and fed it to rats for 90 days. This follows the standard subchronic toxicity protocol used for novel food ingredients worldwide. It is the kind of study regulators expect before GRAS or novel food approvals.

The dosing included a high-dose group at 8,000 mg/kg/day. Body weight, food consumption, clinical observations, hematology, and organ pathology were all assessed.

Key findings at a glance

Parameter	Result
Study design	90-day oral toxicity in rats
Production strain	Genetically engineered E. coli AS10
NOAEL	8,000 mg/kg body weight/day
Solubility	Comparable to sucrose
Texture profile	Comparable to sucrose
Thermal stability	Comparable to sucrose

Scale that NOAEL to a 70 kg adult. It works out to roughly 560 grams per day. No formulator will ever approach that intake in a finished product. The safety margin is wide. The data also confirms the ingredient behaves like sucrose in processing conditions. You can swap it into your existing lines without major rework.

What this means for your supplier evaluation

You do not need to revalidate products already formulated with allulose. This process variant shows the same safety profile you already rely on. But you should ask deeper questions before committing to a new source.

Ask your supplier which strain they use. Ask what purification steps follow fermentation. Ask for the full study report to sit alongside your regulatory documentation. This study used one specific strain. Another manufacturer might use a different chassis or a different downstream process. The safety data applies to the AS10 route. Insist on documentation for your exact supply chain.

Frequently asked questions

Does fermentation-derived allulose differ chemically from enzymatic allulose? The molecule is the same. D-allulose is D-allulose regardless of the route. The difference is in manufacturing efficiency, not the final ingredient.

Can I cite this study in my own regulatory submission? Yes. It adds to the existing evidence base for allulose safety. Pair it with your supplier's own specifications and any additional studies they provide.

Does one-step fermentation change pricing? Fewer processing steps generally mean lower capital and operating costs. The exact market price depends on yield, purification efficiency, and scale. This study removes a regulatory roadblock that could have slowed commercialization.

A clear path for your next launch

This study answers the biggest question formulators had about fermentation-derived allulose. Is it safe? Yes. Does it behave like sucrose? Yes. Is the data strong enough to support a sourcing decision? The 90-day NOAEL says it is.

Keep this paper in your regulatory files. When your compliance team asks about the new supplier, you have the answer ready. The ingredient buyers who move early on this production route will have leverage in cost negotiations that others will not.